Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingda Zhu

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Optics Express|February 1, 2024
Improved PGC demodulation algorithm for fiber optic interferometric sensorsMingda Zhu, Xinxin Wang, Jiaying Chang, et al.
Peerj|April 20, 2022
ELOVL2-AS1 inhibits migration of triple negative breast cancerMingda Zhu, Jingyang Zhang, Guangyu Li, et al.
Scientific Reports|March 5, 2020
A comparative study among machine learning and numerical models for simulating groundwater dynamics in the Heihe River Basin, northwestern ChinaChong Chen, Wei He, Han Zhou, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
Changes in HER2, ER, PR, and Ki-67 in HER2-Negative Breast Cancer After Neoadjuvant Chemotherapy: A Case-Control StudyYouzhao Ma, Yan Yang, Mingda Zhu, et al.
Genetics Research|April 22, 2026
EMP3 Expression in HER2-Enriched Breast Cancer is Linked to PI3K/AKT Signaling and Indicates Poor PrognosisMingda Zhu, Chenyang Tian, Ninine Marthe Nkenfag, et al.
Cancer Research and Treatment|April 6, 2023
Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant ChemotherapyYouzhao Ma, Mingda Zhu, Jingyang Zhang, et al.
Cancer Medicine|March 23, 2023
Impact of residual disease biomarkers on the prognosis of HER2-positive breast cancer following neoadjuvant therapyYouzhao Ma, Mingda Zhu, Minhao Lv, et al.
Breast (Edinburgh, Scotland)|April 18, 2025
Efficacy of adjuvant capecitabine in triple-negative breast cancer with residual disease after neoadjuvant therapy: a real-world studyYouzhao Ma, Mingda Zhu, Jingyang Zhang, et al.
Cell Cycle (Georgetown, Tex.)|May 14, 2024
NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathwayPing Ma, Huajiao Yu, Mingda Zhu, et al.
Journal of Hazardous Materials|March 16, 2024
New insights into changes in phosphorus profile at sediment-water interface by microplastics: Role of benthic bioturbationXiaojun Song, Jiannan Ding, Yunbo Zhang, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Optics Express|February 1, 2024
Improved PGC demodulation algorithm for fiber optic interferometric sensorsMingda Zhu, Xinxin Wang, Jiaying Chang, et al.
Peerj|April 20, 2022
ELOVL2-AS1 inhibits migration of triple negative breast cancerMingda Zhu, Jingyang Zhang, Guangyu Li, et al.
Scientific Reports|March 5, 2020
A comparative study among machine learning and numerical models for simulating groundwater dynamics in the Heihe River Basin, northwestern ChinaChong Chen, Wei He, Han Zhou, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
Changes in HER2, ER, PR, and Ki-67 in HER2-Negative Breast Cancer After Neoadjuvant Chemotherapy: A Case-Control StudyYouzhao Ma, Yan Yang, Mingda Zhu, et al.
Genetics Research|April 22, 2026
EMP3 Expression in HER2-Enriched Breast Cancer is Linked to PI3K/AKT Signaling and Indicates Poor PrognosisMingda Zhu, Chenyang Tian, Ninine Marthe Nkenfag, et al.
Cancer Research and Treatment|April 6, 2023
Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant ChemotherapyYouzhao Ma, Mingda Zhu, Jingyang Zhang, et al.
Cancer Medicine|March 23, 2023
Impact of residual disease biomarkers on the prognosis of HER2-positive breast cancer following neoadjuvant therapyYouzhao Ma, Mingda Zhu, Minhao Lv, et al.
Breast (Edinburgh, Scotland)|April 18, 2025
Efficacy of adjuvant capecitabine in triple-negative breast cancer with residual disease after neoadjuvant therapy: a real-world studyYouzhao Ma, Mingda Zhu, Jingyang Zhang, et al.
Cell Cycle (Georgetown, Tex.)|May 14, 2024
NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathwayPing Ma, Huajiao Yu, Mingda Zhu, et al.
Journal of Hazardous Materials|March 16, 2024
New insights into changes in phosphorus profile at sediment-water interface by microplastics: Role of benthic bioturbationXiaojun Song, Jiannan Ding, Yunbo Zhang, et al.
Pageof 2